Simulations Plus Signs Research Collaboration Agreement with FDA

[Business Wire] – Simulations Plus, Inc. , a leading provider of software for pharmaceutical discovery and development, announced that it has signed a five-year research collaboration agreement with the U.S. more

View todays social media effects on SLP

View the latest stocks trending across Twitter. Click to view dashboard

See who Simulations is hiring next, click here to view